CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

(+)-Pinocembrin 5mg  | 99%

CSNpharm

(+)-Pinocembrin could inhibit p53 expression causing a lower Bax/Bcl-2 ratio and the release of cytochrome c that shows a neuroprotective effects. (+)-Pinocembrin can be extracted from the fruit of alpinia katsunadia hayata with antioxidant and anti-inflammatory antivities.

More Information Supplier Page

(+)-Pinocembrin 25mg  | 99%

CSNpharm

(+)-Pinocembrin could inhibit p53 expression causing a lower Bax/Bcl-2 ratio and the release of cytochrome c that shows a neuroprotective effects. (+)-Pinocembrin can be extracted from the fruit of alpinia katsunadia hayata with antioxidant and anti-inflammatory antivities.

More Information Supplier Page

(+)-Pinocembrin 100mg  | 99%

CSNpharm

(+)-Pinocembrin could inhibit p53 expression causing a lower Bax/Bcl-2 ratio and the release of cytochrome c that shows a neuroprotective effects. (+)-Pinocembrin can be extracted from the fruit of alpinia katsunadia hayata with antioxidant and anti-inflammatory antivities.

More Information Supplier Page

(+)-Pinocembrin 10mg  | 99%

CSNpharm

(+)-Pinocembrin could inhibit p53 expression causing a lower Bax/Bcl-2 ratio and the release of cytochrome c that shows a neuroprotective effects. (+)-Pinocembrin can be extracted from the fruit of alpinia katsunadia hayata with antioxidant and anti-inflammatory antivities.

More Information Supplier Page

(±)-SLV319 100mg  | 99%

CSNpharm

(±)-SLV319 is a selective antagonist of cannabinoid-1 (CB1) receptor with Ki value of 7.8 nM and it has a weaker activation effect on CB2.

More Information Supplier Page

(±)-SLV319 10mg  | 99%

CSNpharm

(±)-SLV319 is a selective antagonist of cannabinoid-1 (CB1) receptor with Ki value of 7.8 nM and it has a weaker activation effect on CB2.

More Information Supplier Page

(±)-SLV319 5mg  | 99%

CSNpharm

(±)-SLV319 is a selective antagonist of cannabinoid-1 (CB1) receptor with Ki value of 7.8 nM and it has a weaker activation effect on CB2.

More Information Supplier Page

(±)-SLV319 50mg  | 99%

CSNpharm

(±)-SLV319 is a selective antagonist of cannabinoid-1 (CB1) receptor with Ki value of 7.8 nM and it has a weaker activation effect on CB2.

More Information Supplier Page

(±)-Sulfinpyrazone 100mg  | 98%

CSNpharm

(±)-Sulfinpyrazone is one of the most studied platelet COX inhibitors, also a uricosuric agent that competitively inhibits uric acid reabsorption in kidney proximal tubules.

More Information Supplier Page

(±)-Sulfinpyrazone 25mg  | 98%

CSNpharm

(±)-Sulfinpyrazone is one of the most studied platelet COX inhibitors, also a uricosuric agent that competitively inhibits uric acid reabsorption in kidney proximal tubules.

More Information Supplier Page

(R)-(-)-Ibuprofen 1g  | 99%

CSNpharm

(R)-(-)-Ibuprofen, the less active enantiomer of ibuprofen, is an inhibitor of COX1 and 2 with IC50 of 13 and 370 μM respectively, it’s a nonsteroidal anti-inflammatory.

More Information Supplier Page

(R)-(-)-Ibuprofen 100mg  | 99%

CSNpharm

(R)-(-)-Ibuprofen, the less active enantiomer of ibuprofen, is an inhibitor of COX1 and 2 with IC50 of 13 and 370 μM respectively, it’s a nonsteroidal anti-inflammatory.

More Information Supplier Page

(R)-(-)-Ibuprofen 250mg  | 99%

CSNpharm

(R)-(-)-Ibuprofen, the less active enantiomer of ibuprofen, is an inhibitor of COX1 and 2 with IC50 of 13 and 370 μM respectively, it’s a nonsteroidal anti-inflammatory.

More Information Supplier Page

(R)-(-)-Phenylephrine HCl 100mg  | 98%

CSNpharm

(R)-(-)-Phenylephrine HCl is both an agonist for α1-adrenoceptor and a phenylephrine, which promotes hypertrophic growth in the ventricular myocytes, and activates several MAPK signaling pathways.

More Information Supplier Page

(R)-(-)-Phenylephrine HCl 25mg  | 98%

CSNpharm

(R)-(-)-Phenylephrine HCl is both an agonist for α1-adrenoceptor and a phenylephrine, which promotes hypertrophic growth in the ventricular myocytes, and activates several MAPK signaling pathways.

More Information Supplier Page

(R)-(-)-Rolipram 50mg  | 98%

CSNpharm

(R)-(-)-rolipram, R-enantiomer of rolipram, is a potent and cAMP-specific PDE4 inhibitor with IC50 of 0.22 μM and 2.5-fold more potent than(+)-rolipram (IC50= 2.58 μM) in inhibiting membrane-bound PDE 4.

More Information Supplier Page

(R)-(-)-Rolipram 5mg  | 98%

CSNpharm

(R)-(-)-rolipram, R-enantiomer of rolipram, is a potent and cAMP-specific PDE4 inhibitor with IC50 of 0.22 μM and 2.5-fold more potent than(+)-rolipram (IC50= 2.58 μM) in inhibiting membrane-bound PDE 4.

More Information Supplier Page

(R)-(-)-Rolipram 1mg  | 98%

CSNpharm

(R)-(-)-rolipram, R-enantiomer of rolipram, is a potent and cAMP-specific PDE4 inhibitor with IC50 of 0.22 μM and 2.5-fold more potent than(+)-rolipram (IC50= 2.58 μM) in inhibiting membrane-bound PDE 4.

More Information Supplier Page

(R)-(-)-Rolipram 10mg  | 98%

CSNpharm

(R)-(-)-rolipram, R-enantiomer of rolipram, is a potent and cAMP-specific PDE4 inhibitor with IC50 of 0.22 μM and 2.5-fold more potent than(+)-rolipram (IC50= 2.58 μM) in inhibiting membrane-bound PDE 4.

More Information Supplier Page

(R)-(+)-Etomoxir Sodium 10mg  | 98%

CSNpharm

(R)-(+)-etomoxir sodium salt is inhibitor of carnitine palmitoyltransferase I (CPT1) and can reduce β-oxidation in mitochondria. It shows inhibition of cardiolipin biosynthesis.

More Information Supplier Page

(R)-(+)-Etomoxir Sodium 5mg  | 98%

CSNpharm

(R)-(+)-etomoxir sodium salt is inhibitor of carnitine palmitoyltransferase I (CPT1) and can reduce β-oxidation in mitochondria. It shows inhibition of cardiolipin biosynthesis.

More Information Supplier Page

(R)-(+)-Etomoxir Sodium 50mg  | 98%

CSNpharm

(R)-(+)-etomoxir sodium salt is inhibitor of carnitine palmitoyltransferase I (CPT1) and can reduce β-oxidation in mitochondria. It shows inhibition of cardiolipin biosynthesis.

More Information Supplier Page

(R)-Baclofen 50mg  | 98%

CSNpharm

(R)-Baclofen is a derivative of gamma-aminobutyric acid with the selective activation of GABAB receptor that is used to treat spasticity.

More Information Supplier Page

(R)-Baclofen 10mg  | 98%

CSNpharm

(R)-Baclofen is a derivative of gamma-aminobutyric acid with the selective activation of GABAB receptor that is used to treat spasticity.

More Information Supplier Page

(R)-Baclofen 5mg  | 98%

CSNpharm

(R)-Baclofen is a derivative of gamma-aminobutyric acid with the selective activation of GABAB receptor that is used to treat spasticity.

More Information Supplier Page

(R)-GNE-140 10mg  | 98%

CSNpharm

(R)-GNE-140 is a potent lactate dehydrogenase A (LDHA) inhibitor with IC50s of 3 nM and 5 nM for LDHA and LDHB respectively.

More Information Supplier Page

(R)-GNE-140 100mg  | 98%

CSNpharm

(R)-GNE-140 is a potent lactate dehydrogenase A (LDHA) inhibitor with IC50s of 3 nM and 5 nM for LDHA and LDHB respectively.

More Information Supplier Page

(R)-GNE-140 50mg  | 98%

CSNpharm

(R)-GNE-140 is a potent lactate dehydrogenase A (LDHA) inhibitor with IC50s of 3 nM and 5 nM for LDHA and LDHB respectively.

More Information Supplier Page

(R)-GNE-140 1mg  | 98%

CSNpharm

(R)-GNE-140 is a potent lactate dehydrogenase A (LDHA) inhibitor with IC50s of 3 nM and 5 nM for LDHA and LDHB respectively.

More Information Supplier Page

(R)-GNE-140 5mg  | 98%

CSNpharm

(R)-GNE-140 is a potent lactate dehydrogenase A (LDHA) inhibitor with IC50s of 3 nM and 5 nM for LDHA and LDHB respectively.

More Information Supplier Page

(S)-(+)-Ibuprofen 1g  | 98%

CSNpharm

S(+)-ibuprofen, the S-enantiomer of ibuprofen, is capable of inhibiting cyclooxygenase (COX) at clinically relevant concentrations, R(-)-ibuprofen is not a COX inhibitor. S(+)-Ibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways

More Information Supplier Page